vs
RadNet, Inc.（RDNT）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是RadNet, Inc.的1.7倍（$906.4M vs $547.7M），Rollins, Inc.净利率更高（11.9% vs -0.1%，领先12.0%），RadNet, Inc.同比增速更快（14.8% vs 10.2%），过去两年RadNet, Inc.的营收复合增速更高（12.6% vs 0.8%）
RadNet是美国领先的放射医疗服务企业，总部位于加利福尼亚州洛杉矶，是美国规模最大的独立固定地址诊断影像中心运营商，按网点数量及年度影像业务收入计均居行业首位。截至2025年，该公司在全美8个州持有或运营超400家影像中心，提供门诊诊断影像服务。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
RDNT vs ROL — 直观对比
营收规模更大
ROL
是对方的1.7倍
$547.7M
营收增速更快
RDNT
高出4.6%
10.2%
净利率更高
ROL
高出12.0%
-0.1%
两年增速更快
RDNT
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $547.7M | $906.4M |
| 净利润 | $-597.0K | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | 5.1% | 16.1% |
| 净利率 | -0.1% | 11.9% |
| 营收同比 | 14.8% | 10.2% |
| 净利润同比 | -111.2% | 2.5% |
| 每股收益（稀释后） | $0.00 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RDNTROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $547.7M | $912.9M | ||
| Q3 25 | $522.9M | $1.0B | ||
| Q2 25 | $498.2M | $999.5M | ||
| Q1 25 | $471.4M | $822.5M | ||
| Q4 24 | $477.1M | $832.2M | ||
| Q3 24 | $461.1M | $916.3M | ||
| Q2 24 | $459.7M | $891.9M |
净利润RDNTROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-597.0K | $116.4M | ||
| Q3 25 | $5.4M | $163.5M | ||
| Q2 25 | $14.5M | $141.5M | ||
| Q1 25 | $-37.9M | $105.2M | ||
| Q4 24 | $5.3M | $105.7M | ||
| Q3 24 | $3.2M | $136.9M | ||
| Q2 24 | $-3.0M | $129.4M |
营业利润率RDNTROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 5.1% | 17.5% | ||
| Q3 25 | 5.2% | 21.9% | ||
| Q2 25 | 6.2% | 19.8% | ||
| Q1 25 | -5.1% | 17.3% | ||
| Q4 24 | 5.1% | 18.1% | ||
| Q3 24 | 7.4% | 20.9% | ||
| Q2 24 | 7.6% | 20.4% |
净利率RDNTROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | -0.1% | 12.8% | ||
| Q3 25 | 1.0% | 15.9% | ||
| Q2 25 | 2.9% | 14.2% | ||
| Q1 25 | -8.0% | 12.8% | ||
| Q4 24 | 1.1% | 12.7% | ||
| Q3 24 | 0.7% | 14.9% | ||
| Q2 24 | -0.6% | 14.5% |
每股收益（稀释后）RDNTROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $0.00 | $0.24 | ||
| Q3 25 | $0.07 | $0.34 | ||
| Q2 25 | $0.19 | $0.29 | ||
| Q1 25 | $-0.51 | $0.22 | ||
| Q4 24 | $0.08 | $0.22 | ||
| Q3 24 | $0.04 | $0.28 | ||
| Q2 24 | $-0.04 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $767.2M | $116.5M |
| 总债务越低越好 | $1.1B | $650.6M |
| 股东权益账面价值 | $1.1B | $1.4B |
| 总资产 | $3.8B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资RDNTROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $767.2M | $100.0M | ||
| Q3 25 | $804.7M | $127.4M | ||
| Q2 25 | $833.2M | $123.0M | ||
| Q1 25 | $717.3M | $201.2M | ||
| Q4 24 | $740.0M | $89.6M | ||
| Q3 24 | $748.9M | $95.3M | ||
| Q2 24 | $741.7M | $106.7M |
总债务RDNTROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $1.1B | $486.1M | ||
| Q3 25 | $1.1B | $485.7M | ||
| Q2 25 | $1.1B | $485.3M | ||
| Q1 25 | $1.0B | $485.5M | ||
| Q4 24 | $1.0B | $395.3M | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — |
股东权益RDNTROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | $932.3M | $1.4B | ||
| Q1 25 | $898.1M | $1.4B | ||
| Q4 24 | $902.3M | $1.3B | ||
| Q3 24 | $895.3M | $1.3B | ||
| Q2 24 | $881.0M | $1.2B |
总资产RDNTROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $3.8B | $3.1B | ||
| Q3 25 | $3.7B | $3.2B | ||
| Q2 25 | $3.5B | $3.2B | ||
| Q1 25 | $3.3B | $2.9B | ||
| Q4 24 | $3.3B | $2.8B | ||
| Q3 24 | $3.3B | $2.8B | ||
| Q2 24 | $3.2B | $2.8B |
负债/权益比RDNTROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 1.00× | 0.35× | ||
| Q3 25 | 1.04× | 0.32× | ||
| Q2 25 | 1.18× | 0.34× | ||
| Q1 25 | 1.12× | 0.36× | ||
| Q4 24 | 1.13× | 0.30× | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.17× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $84.2M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流RDNTROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $84.2M | $164.7M | ||
| Q3 25 | $52.8M | $191.3M | ||
| Q2 25 | $120.3M | $175.1M | ||
| Q1 25 | $41.5M | $146.9M | ||
| Q4 24 | $42.5M | $188.2M | ||
| Q3 24 | $57.4M | $146.9M | ||
| Q2 24 | $116.0M | $145.1M |
自由现金流RDNTROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $168.0M | ||
| Q1 25 | — | $140.1M | ||
| Q4 24 | — | $184.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $136.4M |
自由现金流率RDNTROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | — | 17.4% | ||
| Q3 25 | — | 17.8% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 15.3% |
资本支出强度RDNTROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.0% |
现金转化率RDNTROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | 9.75× | 1.17× | ||
| Q2 25 | 8.33× | 1.24× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | 7.96× | 1.78× | ||
| Q3 24 | 17.89× | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
ROL
暂无分部数据
